22 results
8-K
EX-14.1
DAWN
Day One Biopharmaceuticals, Inc.
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
of skills, abilities, experiences and perspectives is essential to our success. Creativity and innovation flourish in an environment of openness
PRE 14A
at1d3 239
18 Apr 23
Preliminary proxy
4:05pm
DEF 14A
hs2nmrly 3f5
28 Apr 22
Definitive proxy
4:44pm
10-K
r2u2r9thehlv2k1l
7 Mar 22
Annual report
7:36am
10-Q
4f8l98w25
10 Aug 21
Quarterly report
5:26pm
424B4
arypm
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
5tdx69a3jlmd
24 May 21
IPO registration (amended)
6:16am